Trial intelligence / Profile preview

Pre-operative Enoxaparin in Orthopedic Trauma Surgery

NCT05081375Phase 4Terminated

Sponsor
Valleywise Health
Start
Dec 2019
Primary completion
Nov 2023
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of enoxaparin in deep vein thrombosis (DVT), pulmonary embolism (PE), sponsored by Valleywise Health. Started Dec 2019; status: terminated.

02

Drugs

enoxaparin
03

Conditions

deep vein thrombosis (DVT)pulmonary embolism (PE)

Beyond the preview

Go deeper on NCT05081375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05081375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call